Alvotech (ALVO)
USD 8.77
(6.95%)
USD 8.77
(6.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 285.43 Million USD | -21.88% |
| 2022 | 365.37 Million USD | 34.22% |
| 2021 | 272.22 Million USD | 33.35% |
| 2020 | 204.15 Million USD | 118.66% |
| 2019 | 93.36 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 65.35 Million USD | -11.83% |
| 2024 Q2 | 61.67 Million USD | -5.63% |
| 2023 Q2 | 68.4 Million USD | -6.35% |
| 2023 Q1 | 73.04 Million USD | -3.78% |
| 2023 FY | 285.43 Million USD | -21.88% |
| 2023 Q3 | 69.86 Million USD | 2.14% |
| 2023 Q4 | 74.12 Million USD | 6.09% |
| 2022 Q1 | 70.97 Million USD | 250.82% |
| 2022 FY | 365.37 Million USD | 34.22% |
| 2022 Q4 | 75.91 Million USD | 19.41% |
| 2022 Q3 | 63.57 Million USD | -58.96% |
| 2022 Q2 | 154.91 Million USD | 118.29% |
| 2021 FY | 272.22 Million USD | 33.35% |
| 2021 Q2 | 573.8 Thousand USD | 5.18% |
| 2021 Q3 | 75.58 Million USD | 13072.29% |
| 2021 Q4 | 20.23 Million USD | -73.23% |
| 2021 Q1 | 545.56 Thousand USD | 131.82% |
| 2020 FY | 204.15 Million USD | 118.66% |
| 2020 Q4 | 235.33 Thousand USD | 100.46% |
| 2020 Q3 | -51.03 Million USD | 0.0% |
| 2020 Q2 | -51.03 Million USD | 0.0% |
| 2020 Q1 | -51.03 Million USD | -118.66% |
| 2019 Q1 | -23.34 Million USD | 0.0% |
| 2019 Q2 | -23.34 Million USD | 0.0% |
| 2019 Q3 | -23.34 Million USD | 0.0% |
| 2019 Q4 | -23.34 Million USD | 0.0% |
| 2019 FY | 93.36 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -3358.651% |
| Alpha Teknova, Inc. | 45.85 Million USD | -522.425% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -45.644% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -536.371% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -79.286% |
| Cosmos Health Inc. | 26.18 Million USD | -990.258% |
| Journey Medical Corporation | 54.59 Million USD | -422.838% |
| Embecta Corp. | 528.4 Million USD | 45.981% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -4.98% |
| Dynavax Technologies Corporation | 219.14 Million USD | -30.251% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 51.621% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 12.543% |
| PainReform Ltd. | 9.58 Million USD | -2878.276% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2074.854% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -2074.854% |
| SCYNEXIS, Inc. | 51.84 Million USD | -450.528% |
| Safety Shot Inc | 12.1 Million USD | -2257.103% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -9200.115% |
| Procaps Group, S.A. | 199.47 Million USD | -43.093% |
| Theratechnologies Inc. | 72.75 Million USD | -292.322% |
| Harrow Health, Inc. | 89.97 Million USD | -217.249% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -2921.787% |
| Biofrontera Inc. | 39.95 Million USD | -614.327% |
| DURECT Corporation | 43.71 Million USD | -552.952% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 46.043% |
| Cronos Group Inc. | 96.7 Million USD | -195.151% |
| OptiNose, Inc. | 85.1 Million USD | -235.407% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -22.968% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -629.032% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 3085.441% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 9.135% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -2833.335% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -563.184% |
| Radius Health, Inc. | 265.92 Million USD | -7.336% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -1962.129% |
| ProPhase Labs, Inc. | 37.85 Million USD | -654.09% |
| Phibro Animal Health Corporation | 260.29 Million USD | -9.658% |
| Procaps Group S.A. | 187.24 Million USD | -52.441% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -2805.221% |
| Viatris Inc. | 5.96 Billion USD | 95.216% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1756.628% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -377.002% |
| SIGA Technologies, Inc. | 22.04 Million USD | -1194.913% |
| Tilray Brands, Inc. | 251.35 Million USD | -13.559% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -482.075% |
| Shineco, Inc. | 17.94 Million USD | -1490.358% |
| PetIQ, Inc. | 192.72 Million USD | -48.106% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -7051.795% |
| Incannex Healthcare Limited | 30.05 Million USD | -849.782% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 82.121% |
| Alimera Sciences, Inc. | 62.64 Million USD | -355.673% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -37334.885% |
| Assertio Holdings, Inc. | 368.58 Million USD | 22.558% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -4749.793% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1502.816% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -1248.377% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1256.509% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -73.028% |
| Hempacco Co., Inc. | 7.59 Million USD | -3657.519% |
| Talphera, Inc. | 11.99 Million USD | -2279.84% |
| Alvotech | 285.43 Million USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -102.85% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 17.241% |
| Currenc Group, Inc. | 24 Million USD | -1089.221% |
| Kamada Ltd. | 45.42 Million USD | -528.358% |
| Indivior PLC | 911 Million USD | 68.668% |
| Evoke Pharma, Inc. | 12.4 Million USD | -2200.131% |
| Flora Growth Corp. | 10.57 Million USD | -2598.157% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -1256.509% |
| Evolus, Inc. | 189.75 Million USD | -50.421% |
| HUTCHMED (China) Limited | 436.23 Million USD | 34.567% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -85.188% |
| Akanda Corp. | 3.48 Million USD | -8093.981% |